- Conditions
- Peripheral Artery Disease
- Interventions
- vonapanitase
- Drug
- Lead sponsor
- Proteon Therapeutics
- Industry
- Eligibility
- 18 Years to 100 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 2019
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 37
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Atherosclerosis of Native Arteries of the Extremities, Unspecified
- Interventions
- Stent implantation
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 299 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2016
- U.S. locations
- 28
- States / cities
- Birminham, Alabama • Los Angeles, California • Atlanta, Georgia + 24 more
- Conditions
- Peripheral Arterial Disease
- Interventions
- Cardiovascular Ingenuity (CVI) Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter, EverCross Percutaneous Transluminal Balloon Catheter
- Device
- Lead sponsor
- Spectranetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 42
- States / cities
- Yuma, Arizona • Fremont, California • Los Angeles, California + 37 more
- Conditions
- Restenosis, Peripheral Arterial Disease
- Interventions
- Paclitaxel, Placebo
- Drug
- Lead sponsor
- Midwest Cardiovascular Research Foundation
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Bettendorf, Iowa
- Conditions
- Peripheral Artery Disease, Peripheral Vascular Disease
- Interventions
- Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 141 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 1
- States / cities
- Santa Clara, California
- Conditions
- Peripheral Arterial Disease
- Interventions
- TIGRIS Vascular Stent, BARD LifeStent
- Device
- Lead sponsor
- W.L.Gore & Associates
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 267 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 34
- States / cities
- Mobile, Alabama • Little Rock, Arkansas • Oceanside, California + 30 more
- Conditions
- Posterior Knee Infiltration
- Interventions
- Ropivacaine with Epinephrine, Ropivacaine
- Drug
- Lead sponsor
- Trinity Health Of New England
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Hartford, Connecticut
- Conditions
- Atherosclerosis of Native Arteries of the Extremities
- Interventions
- ELUVIA (Stent Implantation), Zilver PTX (Stent Implantation)
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 524 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2022
- U.S. locations
- 42
- States / cities
- Yuma, Arizona • Sacramento, California • Gainesville, Florida + 38 more
- Conditions
- Peripheral Arterial Disease
- Interventions
- TORUS Stent Graft System
- Device
- Lead sponsor
- Endologix
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 188 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2025
- U.S. locations
- 32
- States / cities
- Mesa, Arizona • Phoenix, Arizona • Yuma, Arizona + 28 more
- Conditions
- Peripheral Artery Disease, PAD, Claudication, Peripheral Vascular Disease, PVD
- Interventions
- Stealth 360°® OAS
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Critical Limb Ischemia
- Interventions
- treprostinil dienthanolmine sustained release, Placebo
- Drug
- Lead sponsor
- Ochsner Health System
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- New Orleans, Louisiana
- Conditions
- Functional Popliteal Artery Entrapment Syndrome, Popliteal Artery Entrapment Syndrome
- Interventions
- Dysport
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 50 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Redwood City, California
- Conditions
- Peripheral Arterial Disease, Peripheral Vascular Diseases, Arterial Occlusive Diseases
- Interventions
- PTA (Lutonix® 035 DCB Catheter)
- Device
- Lead sponsor
- C. R. Bard
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 1,005 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 73
- States / cities
- Alexander City, Alabama • Chandler, Arizona • Phoenix, Arizona + 63 more
- Conditions
- Peripheral Artery Disease
- Interventions
- Stellarex 0.035" OTW Drug-coated Angioplasty Balloon, EverCross™ 0.035 PTA Balloon Catheter
- Device
- Lead sponsor
- Spectranetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2020
- U.S. locations
- 39
- States / cities
- Yuma, Arizona • Fremont, California • Los Angeles, California + 34 more
- Conditions
- Femoral Artery Stenosis, Popliteal Artery Stenosis, Femoral Artery Occlusion, Popliteal Artery Occlusion
- Interventions
- Standard Uncoated Angioplasty Balloon, Moxy Drug Coated Balloon
- Procedure · Device
- Lead sponsor
- C. R. Bard
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 532 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2018
- U.S. locations
- 42
- States / cities
- Los Angeles, California • Oceanside, California • Orange, California + 34 more
- Conditions
- Peripheral Artery Disease
- Interventions
- vonapanitase, Placebo
- Drug
- Lead sponsor
- Proteon Therapeutics
- Industry
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 9
- States / cities
- Long Beach, California • Denver, Colorado • Gainesville, Florida + 5 more
- Conditions
- Peripheral Artery Disease
- Interventions
- Tack Endovascular System
- Device
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 213 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 36
- States / cities
- Yuma, Arizona • Little Rock, Arkansas • Beverly Hills, California + 31 more
- Conditions
- Peripheral Artery Disease, Atherosclerosis, Artery Diseases, Peripheral, Plaque, Atherosclerotic, Occlusive Arterial Disease
- Interventions
- RANGER™ Paclitaxel Coated Balloon, Paclitaxel, Standard Balloon Angioplasty
- Device · Drug · Procedure
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 20 Years and older
- Enrollment
- 440 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2023
- U.S. locations
- 42
- States / cities
- Fairhope, Alabama • Aurora, Colorado • Stratford, Connecticut + 38 more
- Conditions
- Peripheral Artery Disease
- Interventions
- FLEX Dynamic Scoring Catheter with IN.PACT Admiral DCB
- Combination Product
- Lead sponsor
- VentureMed Group Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Fort Wayne, Indiana
- Conditions
- Peripheral Arterial Disease
- Interventions
- Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTer
- Device
- Lead sponsor
- Avinger, Inc.
- Industry
- Eligibility
- 19 Years and older
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 10 more
- Conditions
- Total Knee Athroplasty
- Interventions
- Periarticular Injection (PAI), Saline Control Periarticular Injection (PAI)
- Drug
- Lead sponsor
- Hospital for Special Surgery, New York
- Other
- Eligibility
- 25 Years to 80 Years
- Enrollment
- 94 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Peripheral Arterial Disease
- Interventions
- Not listed
- Lead sponsor
- Texas Tech University Health Sciences Center
- Other
- Eligibility
- 25 Years to 89 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Lubbock, Texas
- Conditions
- Total Atherosclerotic Occlusion of Femoral Artery
- Interventions
- CTO crossing in femoropopliteal arteries CONNECT II
- Device
- Lead sponsor
- Avinger, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 14
- States / cities
- Little Rock, Arkansas • Sacramento, California • Elk Grove Village, Illinois + 10 more
- Conditions
- Peripheral Arterial Disease, Peripheral Vascular Diseases, Catheterization, Peripheral
- Interventions
- NVS Therapy
- Combination Product
- Lead sponsor
- Alucent Biomedical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 4
- States / cities
- Houma, Louisiana • Saginaw, Michigan • Raleigh, North Carolina + 1 more